DSE:SQURPHARMA Statistics

Total Valuation

DSE:SQURPHARMA has a market cap or net worth of BDT 179.68 billion. The enterprise value is 110.22 billion.

Market Cap	179.68B
Enterprise Value	110.22B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Nov 17, 2025

Share Statistics

DSE:SQURPHARMA has 886.45 million shares outstanding.

Current Share Class	886.45M
Shares Outstanding	886.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.10%
Owned by Institutions (%)	5.26%
Float	495.49M

Valuation Ratios

The trailing PE ratio is 7.11.

PE Ratio	7.11
Forward PE	n/a
PS Ratio	2.24
PB Ratio	1.21
P/TBV Ratio	1.21
P/FCF Ratio	12.35
P/OCF Ratio	8.75
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.18, with an EV/FCF ratio of 7.57.

EV / Earnings	4.36
EV / Sales	1.38
EV / EBITDA	4.18
EV / EBIT	4.56
EV / FCF	7.57

Financial Position

The company has a current ratio of 11.20, with a Debt / Equity ratio of 0.00.

Current Ratio	11.20
Quick Ratio	9.01
Debt / Equity	0.00
Debt / EBITDA	0.03
Debt / FCF	0.05
Interest Coverage	117.87

Financial Efficiency

Return on equity (ROE) is 17.98% and return on invested capital (ROIC) is 9.23%.

Return on Equity (ROE)	17.98%
Return on Assets (ROA)	8.79%
Return on Invested Capital (ROIC)	9.23%
Return on Capital Employed (ROCE)	13.97%
Revenue Per Employee	5.03M
Profits Per Employee	1.59M
Employee Count	15,937
Asset Turnover	0.54
Inventory Turnover	3.05

Taxes

In the past 12 months, DSE:SQURPHARMA has paid 5.29 billion in taxes.

Income Tax	5.29B
Effective Tax Rate	17.29%

Stock Price Statistics

The stock price has decreased by -4.02% in the last 52 weeks. The beta is 0.11, so DSE:SQURPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-4.02%
50-Day Moving Average	210.66
200-Day Moving Average	214.57
Relative Strength Index (RSI)	33.08
Average Volume (20 Days)	356,617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:SQURPHARMA had revenue of BDT 80.13 billion and earned 25.28 billion in profits. Earnings per share was 28.52.

Revenue	80.13B
Gross Profit	38.22B
Operating Income	20.93B
Pretax Income	30.57B
Net Income	25.28B
EBITDA	23.12B
EBIT	20.93B
Earnings Per Share (EPS)	28.52

Full Income Statement

Balance Sheet

The company has 58.33 billion in cash and 668.50 million in debt, giving a net cash position of 69.47 billion or 78.37 per share.

Cash & Cash Equivalents	58.33B
Total Debt	668.50M
Net Cash	69.47B
Net Cash Per Share	78.37
Equity (Book Value)	148.48B
Book Value Per Share	167.50
Working Capital	71.85B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 20.54 billion and capital expenditures -5.99 billion, giving a free cash flow of 14.56 billion.

Operating Cash Flow	20.54B
Capital Expenditures	-5.99B
Free Cash Flow	14.56B
FCF Per Share	16.42

Full Cash Flow Statement

Margins

Gross margin is 47.70%, with operating and profit margins of 26.12% and 31.55%.

Gross Margin	47.70%
Operating Margin	26.12%
Pretax Margin	38.15%
Profit Margin	31.55%
EBITDA Margin	28.86%
EBIT Margin	26.12%
FCF Margin	18.16%

Dividends & Yields

This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 5.92%.

Dividend Per Share	12.00
Dividend Yield	5.92%
Dividend Growth (YoY)	9.09%
Years of Dividend Growth	7
Payout Ratio	38.41%
Buyback Yield	n/a
Shareholder Yield	5.92%
Earnings Yield	14.07%
FCF Yield	8.10%

Dividend Details

Stock Splits

The last stock split was on November 23, 2020. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 23, 2020
Split Type	Forward
Split Ratio	1.05

Scores

DSE:SQURPHARMA has an Altman Z-Score of 16.59 and a Piotroski F-Score of 6.

Altman Z-Score	16.59
Piotroski F-Score	6